2m 2m 2m 2m 2m 2m 2m
Collegium Pharma (COLL)
NASDAQ
$31.06+$0.58 (+1.90%)
Price as of Jun 03, 2026 4:10 PM EDT- $1.1BMarket Cap
- 4.28%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Collegium Pharma (COLL)
$31.06+$0.58 (+1.90%)
COLL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.48 | ||
Change | -$1.30 (-4.09%) | ||
Open | $31.40 | ||
High | $31.76 | ||
Low | $30.43 | ||
Previous Close | $31.78 | ||
Volume | 668,699 | ||
30-Day Average Volume | 460,374 | ||
1-Week Change | -9.77% | ||
1-Month Change | -11.19% | ||
1-Year Change | 4.28% | ||
3-Year Change | 40.92% | ||
5-Year Change | 33.74% | ||
Fundamentals | |||
Shares Outstanding | 32.4M | ||
Total Assets | $1.7B | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $193.5M | ||
Net Income | $14.5M | ||
Free Cash Flow | $56.8M | ||
EBIT | $28.8M | ||
EBITDA | $84.2M | ||
Net Working Capital | $310.7M | ||
EPS | $0.40 | ||
Enterprise Value/EBITDA | 19 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 3 | ||
P/E | 84 | ||
PEG | 7 | ||
Price/Free Cash Flow | 19 | ||
Price/Operating Cash Flow | 19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue